Status:
TERMINATED
Comparison of Caffeine Reduction and Anticholinergic Medications for Treatment of Overactive Bladder
Lead Sponsor:
IWK Health Centre
Conditions:
Overactive Bladder
Eligibility:
FEMALE
Phase:
NA
Brief Summary
The purpose of this study is to assess the effects of caffeine reduction/elimination on urinary symptoms in women with overactive bladders and compare this therapeutic approach to anticholinergic ther...
Detailed Description
Urinary symptoms such as frequency, urgency, nocturia, and incontinence occur in many women. Overactive bladder (OAB) accounts for forty to seventy percent of urinary incontinence. These symptoms can ...
Eligibility Criteria
Inclusion
- Women with OAB symptoms including urgency, frequency (voids ≥8/day), and urge incontinence
- Women who consume \> one cup (250ml) caffeinated beverage per day
- Women who score $ 6 on the QUID Questionnaire for urgency symptoms
Exclusion
- Women currently receiving treatment for OAB symptoms
- Women with narrow angle Glaucoma
- Women taking anticholinergics or loop diuretics
- Women with an untreated urinary tract infection. After resolution of the UTI, and if all other eligibility criteria are met, the woman can be a candidate for inclusion in the study.
- Women with a diagnosis of painful bladder syndrome or other abnormal urinary tract lesions
- Women scoring \>4 on the QUID Questionnaire for stress symptoms
- Women with de novo symptoms following surgery
- Women with major pelvic prolapse
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT00780832
Start Date
May 1 2008
End Date
April 1 2013
Last Update
February 24 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IWK Health Centre
Halifax, Nova Scotia, Canada, B3K 6R8